slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 221,341-221,370
Pages 10,126
Rows per page 30
Component
221,341-221,370 of 303,780
03
The slide uses a strong visual metaphor of a 'Print' button to represent the simplicity of modern manufacturing.Markforged | Results Presentation Deck | 16 slides · Markforged
Deck Investor relations Beat · Attention1 hit
04
Uses a Venn-style diagram to show segment TAMs within the context of the global market.Markforged | Results Presentation Deck | 16 slides · Markforged
Deck Investor relations Beat · InterestLoop · Logic Chain1 hit
05
Hub-and-spoke diagram showing the three pillars of the platform.Markforged | Results Presentation Deck | 16 slides · Markforged
Deck Investor relations Beat · InterestLoop · Logic Chain1 hit
06
The slide uses a circular flywheel diagram to explain the business model's self-reinforcing nature.Markforged | Results Presentation Deck | 16 slides · Markforged
Deck Investor relations Beat · DesireLoop · Logic Chain1 hit
07
The slide uses a three-column layout to present customer success stories with quotes and quantitative growth metrics.Markforged | Results Presentation Deck | 16 slides · Markforged
Deck Investor relations Beat · DesireLoop · Logic Chain1 hit
08
The slide uses a dark background with high-contrast yellow text for emphasis on key metrics.Markforged | Results Presentation Deck | 16 slides · Markforged
Deck Investor relations Beat · DesireLoop · Logic Chain1 hit
09
The chart uses a bar-horizontal format to compare material strength, highlighting the performance of CFR.Markforged | Results Presentation Deck | 16 slides · Markforged
Deck Investor relations Beat · DesireLoop · Logic Chain1 hit
10
The slide uses a timeline-based layout to showcase product innovation and portfolio expansion.Markforged | Results Presentation Deck | 16 slides · Markforged
Deck Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
11
The slide uses a logo-grid layout organized by industry vertical.Markforged | Results Presentation Deck | 16 slides · Markforged
Deck Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
13
The slide uses a grid layout to display 11 executive profiles.Markforged | Results Presentation Deck | 16 slides · Markforged
Deck Investor relations Beat · Action1 hit
15
Includes adjustments for warrant liabilities, contingent earnout liabilities, and other operating expenses.Markforged | Results Presentation Deck | 16 slides · Markforged
Deck Investor relations 1 hit
02
The slide uses a three-column layout to contrast the lead asset with the two core technology platforms.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
03
The chart uses a Gantt-style visualization to show progress across discovery, preclinical, and clinical phases.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
04
Matinas BioPharma | Investor Presentation Deck | 28 slidesMatinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
05
QIDP stands for Qualified Infectious Disease Product.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
Uses a process/timeline diagram to show life cycle management.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
08
The slide highlights business development traction through licensing agreements.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
10
The chart displays survival percentages with corresponding n/N values below each bar group.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
11
The slide uses a timeline-like visualization for each patient to show the rapid decline of fungal load over a short period (12-14 days).Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
12
The slide uses a timeline-based process diagram to illustrate the clinical trial protocol.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
13
IFIs stands for Invasive Fungal Infections.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
14
Case study table showing patient demographics, medical history, and treatment outcomes.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
15
Matinas BioPharma | Investor Presentation Deck | 28 slidesMatinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
16
The slide serves as a transition to the technology/pipeline section of the deck.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
18
Includes a scientific diagram of the LNC structure and a list of key performance attributes.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
19
The slide uses a process diagram to show the self-assembly of lipoplexes into PS-NPs.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
20
Technical slide detailing biological mechanism of drug delivery platform.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
22
The slide compares Matinas' PS-NP technology stability (17 weeks) against Moderna (30 days) and Pfizer/BioNTech (10 weeks) at refrigerated temperatures.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
23
The slide shows quantitative radiance data (p/s/cm²/sr) comparing control groups to PS-NP LUC mRNA groups at various time points.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
24
The slide highlights a partnership with 'Resilience' to scale manufacturing for Matinas Biopharma's therapeutic platforms.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit